Literature DB >> 34408420

Methylation of the RIN3 Promoter is Associated with Transient Ischemic Stroke/Mild Ischemic Stroke with Early Cognitive Impairment.

Meng Miao1, Fang Yuan2, Xiaotian Ma3, Haiming Yang1, Xiang Gao1, Zhengyu Zhu4, Jianzhong Bi4.   

Abstract

BACKGROUND: Early cognitive impairment after transient ischemic stroke (TIA)/mild ischemic stroke (MIS) is common but easily overlooked. It has been demonstrated that DNA methylation plays a significant role in cognitive impairment and ischemic stroke. Furthermore, it has been reported that the RIN3 gene influences transportation of the amyloid β-protein. However, to our knowledge, there has been no research related to correlations between RIN3 methylation and early-onset cognitive impairment after TIA/MIS. Therefore, this study aimed to investigate this relationship in TIA/MIS patients.
METHODS: This study include 28 control subjects and 84 patients with TIA/MIS who were evaluated within 7 days of TIA/MIS onset using four single-domain cognitive scales. In addition, DNA methylation of whole blood was tested. RIN3 methylation was compared between TIA/MIS and control groups and between TIA/MIS patients with early cognitive impairment and those without early cognitive impairment. Clinical variables and RIN3 methylation sites with statistical differences were then used to construct a predictive model.
RESULTS: Hypomethylation of the RIN3 gene was observed in the whole blood of TIA/MIS patients relative to healthy controls. Furthermore, patients with early cognitive impairment after TIA/MIS had hypomethylation of RIN3 relative to those without early cognitive impairment.
CONCLUSION: RIN3 methylation is strongly associated with TIA/MIS and TIA/MIS with early cognitive impairment. It is possible to influence the disease process by methylation via appropriate lifestyle and clinical interventions, and methylation of RIN3 gene sites may predict the occurrence of TIA/MIS with early cognitive impairment.
© 2021 Miao et al.

Entities:  

Keywords:  amyloid Β-protein; cognitive impairment; hypomethylation; ischemic stroke; transportation

Year:  2021        PMID: 34408420      PMCID: PMC8364373          DOI: 10.2147/NDT.S320167

Source DB:  PubMed          Journal:  Neuropsychiatr Dis Treat        ISSN: 1176-6328            Impact factor:   2.570


  37 in total

1.  Is the Montreal Cognitive Assessment superior to the Mini-Mental State Examination to detect poststroke cognitive impairment? A study with neuropsychological evaluation.

Authors:  Olivier Godefroy; Andreas Fickl; Martine Roussel; Caroline Auribault; Jean Marc Bugnicourt; Chantal Lamy; Sandrine Canaple; Gil Petitnicolas
Journal:  Stroke       Date:  2011-04-07       Impact factor: 7.914

2.  Diagnostic Accuracy of Cerebrospinal Fluid Amyloid-β Isoforms for Early and Differential Dementia Diagnosis.

Authors:  Hanne Struyfs; Bianca Van Broeck; Maarten Timmers; Erik Fransen; Kristel Sleegers; Christine Van Broeckhoven; Peter P De Deyn; Johannes R Streffer; Marc Mercken; Sebastiaan Engelborghs
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

3.  Transient cognitive impairment in TIA and minor stroke.

Authors:  Sarah T Pendlebury; Sarah Wadling; Louise E Silver; Ziyah Mehta; Peter M Rothwell
Journal:  Stroke       Date:  2011-09-08       Impact factor: 7.914

4.  Cognitive screening in the acute stroke setting.

Authors:  Daniel J Blackburn; Leila Bafadhel; Marc Randall; Kirsty A Harkness
Journal:  Age Ageing       Date:  2012-08-24       Impact factor: 10.668

5.  Early Cognitive Impairment after Minor Stroke: Associated Factors and Functional Outcome.

Authors:  Satoshi Suda; Takuya Nishimura; Akiko Ishiwata; Kanako Muraga; Junya Aoki; Takuya Kanamaru; Kentaro Suzuki; Yuki Sakamoto; Takehiro Katano; Yasuhiro Nishiyama; Masahiro Mishina; Kazumi Kimura
Journal:  J Stroke Cerebrovasc Dis       Date:  2020-03-14       Impact factor: 2.136

Review 6.  Vascular cognitive impairment and dementia.

Authors:  Philip B Gorelick; Scott E Counts; David Nyenhuis
Journal:  Biochim Biophys Acta       Date:  2015-12-15

7.  Pro-inflammatory S100A9 Protein as a Robust Biomarker Differentiating Early Stages of Cognitive Impairment in Alzheimer's Disease.

Authors:  Istvan Horvath; Xueen Jia; Per Johansson; Chao Wang; Roman Moskalenko; Andreas Steinau; Lars Forsgren; Thomas Wågberg; Johan Svensson; Henrik Zetterberg; Ludmilla A Morozova-Roche
Journal:  ACS Chem Neurosci       Date:  2015-11-12       Impact factor: 4.418

Review 8.  Cerebral amyloid angiopathy: emerging concepts.

Authors:  Masahito Yamada
Journal:  J Stroke       Date:  2015-01-30       Impact factor: 6.967

9.  CDKN2B methylation is associated with carotid artery calcification in ischemic stroke patients.

Authors:  Shuyu Zhou; Yumeng Zhang; Li Wang; Zhizhong Zhang; Biyang Cai; Keting Liu; Hao Zhang; Minhui Dai; Lingli Sun; Xiaomeng Xu; Huan Cai; Xinfeng Liu; Guangming Lu; Gelin Xu
Journal:  J Transl Med       Date:  2016-12-01       Impact factor: 5.531

10.  Upregulation of RIN3 induces endosomal dysfunction in Alzheimer's disease.

Authors:  Ruinan Shen; Xiaobei Zhao; Lu He; Yongbo Ding; Wei Xu; Suzhen Lin; Savannah Fang; Wanlin Yang; Kijung Sung; Brian Spencer; Robert A Rissman; Ming Lei; Jianqing Ding; Chengbiao Wu
Journal:  Transl Neurodegener       Date:  2020-06-18       Impact factor: 8.014

View more
  1 in total

Review 1.  The Cognitive Sequelae of Transient Ischemic Attacks-Recent Insights and Future Directions.

Authors:  Aravind Ganesh; Philip A Barber
Journal:  J Clin Med       Date:  2022-05-07       Impact factor: 4.964

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.